Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Hexham

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|August 15, 1987
The human T3 gamma chain is phosphorylated at serine 126 in response to T lymphocyte activationA A Davies, D A Cantrell, J M Hexham, et al.
The Journal of Experimental Medicine|February 17, 1999
A human immunoglobulin (Ig)A calpha3 domain motif directs polymeric Ig receptor-mediated secretionJ M Hexham, K D White, L N Carayannopoulos, et al.
The Biochemical Journal|June 15, 1989
A protein kinase C pseudosubstrate peptide inhibits phosphorylation of the CD3 antigen in streptolysin-O-permeabilized human T lymphocytesD R Alexander, J M Hexham, S C Lucas, et al.
Molecular Immunology|October 31, 2001
Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxinsJ M Hexham, D Dudas, R Hugo, et al.
Autoimmunity|January 1, 1994
Cloning and characterisation of TPO autoantibodies using combinatorial phage display librariesJ M Hexham, L J Partridge, J Furmaniak, et al.
Biotechnology and Applied Biochemistry|December 4, 2001
Optimization of the anti-(human CD3) immunotoxin DT389-scFv(UCHT1) N-terminal sequence to yield a homogeneous proteinJ M Hexham, V King, D Dudas, et al.
Protein Engineering|January 26, 2002
Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletionJ Thompson, S Stavrou, M Weetall, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 14, 2012
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trialP De Simone, F Nevens, L De Carlis, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
The Journal of Biological Chemistry|August 15, 1987
The human T3 gamma chain is phosphorylated at serine 126 in response to T lymphocyte activationA A Davies, D A Cantrell, J M Hexham, et al.
The Journal of Experimental Medicine|February 17, 1999
A human immunoglobulin (Ig)A calpha3 domain motif directs polymeric Ig receptor-mediated secretionJ M Hexham, K D White, L N Carayannopoulos, et al.
The Biochemical Journal|June 15, 1989
A protein kinase C pseudosubstrate peptide inhibits phosphorylation of the CD3 antigen in streptolysin-O-permeabilized human T lymphocytesD R Alexander, J M Hexham, S C Lucas, et al.
Molecular Immunology|October 31, 2001
Influence of relative binding affinity on efficacy in a panel of anti-CD3 scFv immunotoxinsJ M Hexham, D Dudas, R Hugo, et al.
Autoimmunity|January 1, 1994
Cloning and characterisation of TPO autoantibodies using combinatorial phage display librariesJ M Hexham, L J Partridge, J Furmaniak, et al.
Biotechnology and Applied Biochemistry|December 4, 2001
Optimization of the anti-(human CD3) immunotoxin DT389-scFv(UCHT1) N-terminal sequence to yield a homogeneous proteinJ M Hexham, V King, D Dudas, et al.
Protein Engineering|January 26, 2002
Improved binding of a bivalent single-chain immunotoxin results in increased efficacy for in vivo T-cell depletionJ Thompson, S Stavrou, M Weetall, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 14, 2012
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trialP De Simone, F Nevens, L De Carlis, et al.
Pageof 2